3rd Circ. Says Pa. Fen-Phen Suit Barred By Earlier MDL Deal

Law360, New York (January 28, 2013, 7:30 PM EST) -- The Third Circuit on Monday defeated a Pennsylvania couple’s fen-phen product liability suit against Wyeth Pharmaceuticals Inc. and Pfizer Inc., saying in a precedential opinion that their claims are barred by the 1999 settlement covering multidistrict litigation over the diet drugs’ health risks.

A three-judge panel ruled that a Pennsylvania federal court got it right when it enjoined plaintiffs Carmen Cauthen and Ricky Leon Cauthen’s suit, saying they did not qualify for a cause of action exemption that would have allowed them to proceed with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.